PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,992 | +1.6% | 2,613 | +28.9% | 0.00% | 0.0% |
| Q2 2023 | $26,574 | +17.3% | 2,027 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $22,662 | +22.4% | 2,027 | -7.7% | 0.00% | 0.0% |
| Q4 2022 | $18,512 | -49.4% | 2,196 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $36,585 | +13.2% | 2,196 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $32,325 | -27.6% | 2,196 | +22.0% | 0.00% | -50.0% |
| Q1 2022 | $44,658 | -81.7% | 1,800 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $244,630 | -10.9% | 7,628 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $274,455 | -18.4% | 7,628 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $336,547 | +97.5% | 7,628 | +104.8% | 0.01% | +66.7% |
| Q1 2021 | $170,382 | -33.7% | 3,725 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $257,100 | – | 3,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,003,000 | 6.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,720,901 | $61,990,000 | 1.23% |
| NEXT CENTURY GROWTH INVESTORS LLC | 454,614 | $7,573,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 778,978 | $12,978,000 | 0.75% |
| Novo Holdings A/S | 510,555 | $8,506,000 | 0.41% |
| Champlain Investment Partners, LLC | 2,802,460 | $46,689,000 | 0.32% |
| TimesSquare Capital Management, LLC | 1,223,754 | $20,388,000 | 0.28% |
| Rock Springs Capital Management LP | 597,400 | $9,953,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 29,150 | $486,000 | 0.18% |
| RTW INVESTMENTS, LP | 460,847 | $7,678,000 | 0.18% |